Pretreatment serum vitamin D levels predict the therapeutic efficacy of atezolizumab plus bevacizumab therapy in advanced hepatocellular carcinoma: a multicenter analysis - PubMed
3 hours ago
- #Vitamin D
- #Immunotherapy
- #Hepatocellular Carcinoma
- Pretreatment serum vitamin D levels may predict therapeutic efficacy of atezolizumab plus bevacizumab in advanced hepatocellular carcinoma.
- A cutoff of 17.8 ng/mL for vitamin D was identified; levels ≥17.8 ng/mL were associated with better overall survival.
- High vitamin D levels (≥17.8 ng/mL) and modified albumin-bilirubin grade were independent prognostic factors for overall survival.